Santen, Inc.

Founded in 1890 in Osaka, Japan, Santen is one of the leading prescription ophthalmic companies in the world today. Today, Santen is involved in the development, manufacture, sale, export, and import of ophthalmic pharmaceuticals, chemicals, reagents, and medical equipment around the globe. Santen remains committed to research and development in the area of its greatest expertise: leading-edge ethical ophthalmics. Publicly listed on the Tokyo Stock Exchange since 1963, Santen's prescription eye product sales are rapidly approaching $1 billion annually. Europe: Established Santen Pharmaceutical Support GmbH (Munich) in 1996 , Formed Santen European holding company (Santen B.V., Netherlands) in 1996, Established pharmaceutical manufacturing capability in Europe and market position in Scandinavia via acquisition (Santen Oy, Finland) in 1997

Activity:

- Manufacturing

Product / Technology type(s) covered:

- API / chemicals
- Reagents

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active: Asia , North America , Europe

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: